Literature DB >> 23557785

MicroRNAs in pluripotency, reprogramming and cell fate induction.

Patrick Lüningschrör1, Stefan Hauser, Barbara Kaltschmidt, Christian Kaltschmidt.   

Abstract

Pluripotent stem cells display a unique expression pattern of microRNAs (miRNAs). These ~22 nucleotide non-coding RNAs have established a crucial role in controlling gene expression of pluripotent stem cells at the post-transcriptional level. Recent studies made important advances in identifying miRNA regulated processes like de novo DNA methylation, progression of the cell cycle and regulation of cell fate decision. miRNAs have also the ability to reprogram somatic cells to pluripotent stem cells and on the other hand, to induce differentiation of pluripotent stem cells into distinct somatic lineages. Previously it was published that miRNAs can direct reprogramming on its own. Here we provide evidence and critically discuss that the effect of miRNA depends on co-expression of the classical reprogramming factors. During transition between these different cell fates distinct miRNAs adjust the levels of specific transcriptional programs and confer robustness to differentiation processes. This results in a complex network between miRNAs and their targets. The fact that miRNAs itself can also be regulated by its targets establishes complex regulatory loops. Based on bioinformatical predictions, each miRNA theoretically has hundreds of target genes making it even more challenging to understand the complete network between miRNAs and their targets.
Copyright © 2013 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23557785     DOI: 10.1016/j.bbamcr.2013.03.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Concise review: new frontiers in microRNA-based tissue regeneration.

Authors:  Jessica E Frith; Enzo R Porrello; Justin J Cooper-White
Journal:  Stem Cells Transl Med       Date:  2014-05-29       Impact factor: 6.940

Review 2.  MicroRNA-Mediated Reprogramming of Somatic Cells into Neural Stem Cells or Neurons.

Authors:  Hao Yang; Lingling Zhang; Jing An; Qian Zhang; Cuicui Liu; Baorong He; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 3.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

Review 4.  The presence, role and clinical use of spermatozoal RNAs.

Authors:  Meritxell Jodar; Sellappan Selvaraju; Edward Sendler; Michael P Diamond; Stephen A Krawetz
Journal:  Hum Reprod Update       Date:  2013-07-14       Impact factor: 15.610

Review 5.  MicroRNA delivery for regenerative medicine.

Authors:  Bo Peng; Yongming Chen; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

6.  GSK3 inhibitors CHIR99021 and 6-bromoindirubin-3'-oxime inhibit microRNA maturation in mouse embryonic stem cells.

Authors:  Yongyan Wu; Fayang Liu; Yingying Liu; Xiaolei Liu; Zhiying Ai; Zekun Guo; Yong Zhang
Journal:  Sci Rep       Date:  2015-03-02       Impact factor: 4.379

Review 7.  The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesis.

Authors:  Hara Kang; Akiko Hata
Journal:  BMB Rep       Date:  2015-06       Impact factor: 4.778

8.  Comparative Characterization of Cardiac Development Specific microRNAs: Fetal Regulators for Future.

Authors:  Yashika Rustagi; Hitesh K Jaiswal; Kamal Rawal; Gopal C Kundu; Vibha Rani
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

Review 9.  RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Authors:  Juan A Bernal
Journal:  J Cardiovasc Transl Res       Date:  2013-07-13       Impact factor: 4.132

10.  Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium.

Authors:  Heuy-Ching Wang; Whitney A Greene; Ramesh R Kaini; Jane Shen-Gunther; Hung-I H Chen; Hong Cai; Yufeng Wang
Journal:  Cancer Inform       Date:  2014-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.